Background Stroke and thromboembolic events may still occur in “clinically low‐risk” atrial
fibrillation (AF) patients as categorized by CHA 2 DS 2‐VAS c score. Our aim was to assess
the proportion of “clinically low‐risk” patients using a nongender CHA 2 DS 2‐VAS c (ie,
CHA 2 DS 2‐VA) score of 0 to 1 among patients who experienced AF‐associated stroke and
to identify markers associated with stroke in “clinically low‐risk” patients. Methods and
Results We retrospectively recruited nonvalvular AF patients who experienced embolic …